---
title: "Plus Therapeutics GAAP EPS of -$1.31 misses by $0.45; reaffirms FY outlook"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296058426.md"
description: "Plus Therapeutics GAAP EPS of -$1.31 misses by $0.45; reaffirms FY outlook"
datetime: "2026-08-17T05:16:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296058426.md)
  - [en](https://longbridge.com/en/news/296058426.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296058426.md)
generator: "portal-rs"
---

# Plus Therapeutics GAAP EPS of -$1.31 misses by $0.45; reaffirms FY outlook


### Related Stocks

- [PSTV.US](https://longbridge.com/en/quote/PSTV.US.md)

## Related News & Research

- [ZK International GAAP EPS of -$0.89, revenue of $1M](https://longbridge.com/en/news/296649006.md)
- [Aptorum Group GAAP EPS of -$1.60](https://longbridge.com/en/news/296654186.md)
- [Enveric Biosciences GAAP EPS of -$0.76](https://longbridge.com/en/news/296075035.md)
- [XORTX Therapeutics Inc. GAAP EPS of -$1.05](https://longbridge.com/en/news/296650983.md)
- [Intelligent Bio Solutions GAAP EPS of -$8.44, revenue of $4.22M](https://longbridge.com/en/news/296440057.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**